EMA Approves BioNTech’s COVID-19 Vaccine Manufacturing Site

EMA has approved the manufacturing of drug product for BioNTech’s COVID-19 vaccine, BNT162b2, at BioNTech’s manufacturing site located in Marburg, Germany.